BK Clinical Trials Consulting K/S — Credit Rating and Financial Key Figures

BK Clinical Trials Consulting K/S (CVR number: 37105740) is a company from RUDERSDAL. The company recorded a gross profit of 1564.4 kDKK in 2023. The operating profit was 1555.2 kDKK, while net earnings were 1702.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was 53.4 %, which can be considered excellent and Return on Equity (ROE) was 60.7 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 84.9 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. BK Clinical Trials Consulting K/S's liquidity measured by quick ratio was 6.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.